Form4.ai tracks every SEC insider trade in real time. See every RYTM insider filing with a free account — no card.
See every RYTM insider filing — free account, no card.
Free accountRHYTHM PHARMACEUTICALS, INC. (RYTM) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $26.5M. Most recent filing: Sept. 14, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 14, 2026 SEC filing | Meeker David P President and CEO | Cashless exercise | $4,830,942 | — |
| Sep 1, 2026 SEC filing | Smith Hunter C Chief Financial Officer | Sold | $589,184 | — |
| Aug 17, 2026 SEC filing | Shulman Joseph Chief Technical Officer | Sold | $365,836 | — |
Create a free account to see all 7 RYTM filings from the last 90 days. No card needed.
Create free accountWant RYTM insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.